NASDAQ: $GILD A New Option for HIV Management The landscape of HIV treatment continues to evolve, offering more flexibility for those living with the virus. The FDA has officially approved Bixlenvo, a new medication combining bictegravir and lenacapavir, specifically designed for adults who are already virologically suppressed. Understanding Bixlenvo Bixlenvo is indicated for use in…